সংরক্ষণ করুন:
| প্রধান লেখক: | , , , , |
|---|---|
| বিন্যাস: | Recurso digital |
| ভাষা: | ইংরেজি |
| প্রকাশিত: |
Zenodo
2024
|
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | https://doi.org/10.5281/zenodo.14891755 |
| ট্যাগগুলো: |
ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|
| _version_ | 1866901861208948736 |
|---|---|
| author | Nasrin Izadian Fariba Sanaei Soheila Sadeghi Mohammad-Soroush Khorsand Nikan Shakerinasab |
| author_facet | Nasrin Izadian Fariba Sanaei Soheila Sadeghi Mohammad-Soroush Khorsand Nikan Shakerinasab |
| contents | <p>This study investigates the impact of capital increases on market reactions, focusing specifically on pharmaceutical companies listed on the Tehran Stock Exchange (TSE). We analyze stock returns over a six-month window: three months preceding and three months following the announcement of capital increases. Employing the market model, we assess investor responses and the revaluation of assets associated with these capital injections. Our comprehensive sample includes 200 pharmaceutical firms selected through systematic random sampling, covering the period from 2017 to 2023. The results reveal that asset revaluation significantly enhances investor reactions compared to capital increases stemming from cash contributions and retained earnings. Furthermore, our findings underscore the critical role of information transparency from company management in shaping market responses. This research contributes to a deeper understanding of investor behavior and informs management strategies related to capital restructuring in the dynamic pharmaceutical sector.</p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_14891755 |
| institution | Zenodo |
| language | eng |
| publishDate | 2024 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | Market reactions to capital increases: Insights from asset revaluation in pharmaceutical companies on the stock exchange Nasrin Izadian Fariba Sanaei Soheila Sadeghi Mohammad-Soroush Khorsand Nikan Shakerinasab Market Reaction Capital Increase Pharmaceutical Companies Asset Revaluation Retained Earnings <p>This study investigates the impact of capital increases on market reactions, focusing specifically on pharmaceutical companies listed on the Tehran Stock Exchange (TSE). We analyze stock returns over a six-month window: three months preceding and three months following the announcement of capital increases. Employing the market model, we assess investor responses and the revaluation of assets associated with these capital injections. Our comprehensive sample includes 200 pharmaceutical firms selected through systematic random sampling, covering the period from 2017 to 2023. The results reveal that asset revaluation significantly enhances investor reactions compared to capital increases stemming from cash contributions and retained earnings. Furthermore, our findings underscore the critical role of information transparency from company management in shaping market responses. This research contributes to a deeper understanding of investor behavior and informs management strategies related to capital restructuring in the dynamic pharmaceutical sector.</p> |
| title | Market reactions to capital increases: Insights from asset revaluation in pharmaceutical companies on the stock exchange |
| topic | Market Reaction Capital Increase Pharmaceutical Companies Asset Revaluation Retained Earnings |
| url | https://doi.org/10.5281/zenodo.14891755 |